Irving, Texas – (NewMediaWire) – September 15, 2020 – Minimizing the risk of infection for patients and staff is our
top priority here at Gibson Diagnostic Labs. To effectively do so in the
healthcare world requires facility readiness and workforce availability.
All facilities need to
ensure they are prepared to deliver care and support under the new protocols to
help minimize the risk of infection. Guidance and recommendations on how to
safely operate your facilities are available from several agencies:
The Centers for Medicare and Medicaid
Services (CMS) recommends that facility staff be routinely screened
for COVID-19 symptoms. If a staff member is found symptomatic, testing and
quarantining of the individual should follow.
The Occupational Safety and Health Administration (OSHA)
published a guide on how to prepare your workplace for operating amidst
The Center for Disease Control and
Prevention (CDC) provides updated criteria for healthcare
workers as they navigate their return to work and what steps to take in the
case of COVID-19 symptoms.
The Gibson Diagnostic
Labs team is ready to assist all patients with personalized, professional
service to deliver the highest level of quality diagnostic testing. The staff
continues to work diligently to increase testing capacity on a timely basis in
response to the public health crisis.
To learn more, please
visit Gibson Diagnostic Lab’s COVID-19 testing page.
Gibson Diagnostic Labs
(GDL) is a leading healthcare company that drives better patient care and
healthier lives by incorporating more of a holistic approach to healthcare. At
its core is a relentless focus on information that empowers healthcare
professionals to make better, more informed decisions. GDL delivers advanced,
laboratory diagnostic services to physicians, counselors and clinicians who
share the same commitment to enhance health outcomes and improve lives. It
offers a broad portfolio of diagnostic tests that are aligned with long-term
healthcare trends. Its goal is to help in the prevention, diagnosis, and
treatment of diseases by providing healthcare professionals with clinically
actionable data that promotes patient‐centric, personalized holistic
CONTACT: Anna Benson